United Pharm (033270) — Cash Flow Quality Index
United Pharm (033270) has a Cash Flow Quality Index of 2.54x as of March 2026. Operating cash flow of ₩35.58 Billion exceeds net income of ₩13.98 Billion, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of United Pharm to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
United Pharm Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for United Pharm across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 033270 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for United Pharm (2011–2025)
Year-by-year earnings quality comparison for United Pharm. For live market cap and the full company financial profile, see 033270 market cap.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.33x | ₩51.14 Billion | ₩38.31 Billion | ▲ +61.7% |
| 2024 | 0.83x | ₩26.79 Billion | ₩32.45 Billion | ▼ -19.9% |
| 2023 | 1.03x | ₩49.77 Billion | ₩48.26 Billion | ▼ -26.8% |
| 2022 | 1.41x | ₩63.78 Billion | ₩45.28 Billion | ▼ -8.5% |
| 2021 | 1.54x | ₩44.09 Billion | ₩28.65 Billion | ▲ +10.8% |
| 2020 | 1.39x | ₩36.96 Billion | ₩26.61 Billion | ▲ +12.5% |
| 2019 | 1.23x | ₩38.15 Billion | ₩30.92 Billion | ▲ +6.0% |
| 2018 | 1.16x | ₩36.86 Billion | ₩31.67 Billion | ▲ +17.1% |
| 2017 | 0.99x | ₩27.68 Billion | ₩27.86 Billion | ▼ -35.4% |
| 2016 | 1.54x | ₩30.02 Billion | ₩19.51 Billion | ▲ +32.6% |
| 2014 | 1.16x | ₩21.31 Billion | ₩18.37 Billion | ▼ -25.3% |
| 2013 | 1.55x | ₩18.97 Billion | ₩12.21 Billion | ▲ +16.3% |
| 2012 | 1.34x | ₩21.88 Billion | ₩16.38 Billion | ▼ -2.3% |
| 2011 | 1.37x | ₩27.62 Billion | ₩20.21 Billion | — |